v3.26.1
SEGMENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 24, 2025
Nov. 18, 2021
Nov. 04, 2021
Mar. 31, 2026
Mar. 31, 2025
Mar. 21, 2026
Proceeds from issuance of common stock       $ 4,500 $ 18,858  
Common stock, par value [1]       $ 0.0001 $ 0.0001  
Subscription Agreement [Member]            
Issuance of common stock - At The Market equity offering, shares 666,667     233,333    
Proceeds from issuance of common stock         $ 2,000  
Common stock, par value $ 0.001          
Share price $ 3.00     $ 3.00    
Beyond Cancer Ltd [Member]            
Equity ownership percentage     80.00%      
NeuroNos Ltd [Member]            
Equity ownership percentage 84.75%          
NeuroNos Ltd [Member] | Subscription Agreement [Member]            
Equity ownership percentage       15.25% 11.76% 84.75%
Investors [Member] | Beyond Cancer Ltd [Member]            
Equity ownership percentage     20.00%      
Beyond Cancer Ltd [Member]            
Issuance of common stock - At The Market equity offering, shares     3,000,000      
Shares issued price per share     $ 10.00      
Proceeds from issuance of common stock   $ 30,000        
Amount of terminated loan   4,800        
Proceeds from related party debt   $ 1,100        
Beyond Cancer Ltd [Member] | Related Party [Member]            
Related party invested     $ 1,100      
Beyond Cancer Ltd [Member] | Certain Investors [Member]            
Sle of stock per share     $ 1.00      
[1] Prior period results have been adjusted to reflect the one-for-twenty stock split in July 2025. See Note 1, Organization and Business for details.